Why the study?
Does dipyridamole infusion cause P-wave widening independent of myocardial ischemia in patients undergoing stress imaging?
Does dipyridamole infusion cause P-wave widening independent of myocardial ischemia in patients undergoing stress imaging?
P-wave widening during dipyridamole stress imaging may be a direct pharmacological effect on the atria rather than a reliable indicator of underlying myocardial ischemia.
P-wave widening may reflect direct dipyridamole effect rather than ischemia; hypothesis-generating in case series, needs prospective validation.
P-wave widening on the 12-lead electrocardiogram denotes abnormal atrial depolarization and has been shown to be associated with myocardial ischemia during treadmill exercise tolerance testing. However, its true significance during dipyridamole (Persantine) stress imaging remains questionable given the potential direct as well as indirect effects of dipyridamole on the atria. We present a novel series of 5 comparable cases of dipyridamole stress imaging where serial P-wave duration increase occurred during administration of dipyridamole. We observed that such P-wave widening occurred even in the absence of evidence of myocardial ischemia on subsequent myocardial perfusion imaging. Clinicians should therefore be aware of this potential association where, unlike that observed with graded exercise treadmill testing, P-wave widening during dipyridamole infusion could perhaps be a pharmacological effect on the atria instead of an indication of underlying myocardial ischemia.
No takes yet. Share an insight, caveat, or question.
Prajapat et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: